Carbon monoxide and vascular cell function
Carbon monoxide and vascular cell function
批准号:
8399024
负责人:
WILLIAM DURANTE
金额:
$31.51万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 2015-12-31
关键词:
AmericasAnimal ModelAnimalsAntioxidantsApoptosisApoptoticArterial InjuryArteriesBilirubinBiliverdineBiologicalBlood CirculationBlood PressureBlood VesselsBlood flowCarbon MonoxideCardiovascular DiseasesCarotid ArteriesCarotid Artery InjuriesCell ProliferationCell physiologyCellsCollagenDefense MechanismsDepositionDevelopmentDiabetes MellitusDiseaseDoseEndothelial CellsEndotheliumExcretory functionFunctional disorderGasesGene DeletionGene DeliveryGene TransferGlucoseGrowthHealthHemeHomeostasisHomocysteineHomocystineHumanHyperglycemiaHyperhomocysteinemiaHypertensionInfusion proceduresInjuryInsulinIronLaboratoriesMediatingModalityMolecularNitric OxideNitric Oxide PathwayPathway interactionsPeroxonitritePlasmaPlatelet aggregationPlayProductionProteinsRattusReactive Oxygen SpeciesRegulationRodentRoleSmooth Muscle MyocytesStrokeSuperoxidesSystemTestingTherapeuticUnited StatesVascular DiseasesVasodilationadenoviral-mediatedage effectbaseblood glucose regulationbody systemcell growthcostdiabeticheme oxygenase-1human NOS3 proteinimprovedinhibitor/antagonistmigrationneointima formationnovel therapeuticspreventprotein expressionresearch studyrespiratoryresponserestorationsenescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad long-term objective of this proposal is to establish heme oxygenase-1 (HO-1)-derived carbon monoxide (CO) as a biologically important gas that promotes homeostasis following arterial injury. We have recently demonstrated that gene transfer of HO-1 or the exogenous administration of CO blocks neointima formation following arterial injury, and that this is associated with a marked decrease in vascular smooth muscle cell growth and collagen deposition. We now propose to extend these studies and establish the significance and mechanism by which CO regulates endothelial cell (EC) function following arterial injury and in vascular disease. The central hypothesis of this proposal is that CO plays a critical role in promoting EC growth following arterial injury and that CO reverses endothelial dysfunction in hyperhomocysteinemia and diabetes. We further propose that CO mediates these effects via the activation of eNOS. In aim 1, we will examine the effect of endogenously derived or exogenously administered CO in regulating EC function and regrowth following arterial injury. These studies will investigate the effect of CO on EC proliferation, migration, apoptosis, and senescence, and determine whether the eNOS-mediated release of NO contributes to the biological actions of CO. We will also examine the mechanism by which CO regulates eNOS activity exploring possible transcriptional, postranscriptional, and posttranslational modes of regulation. In addition, we will investigate the effect of HO-1 gene transfer, HO-1 gene deletion, or CO administration on endothelial function and regrowth following carotid artery injury in rodents. In aim 2, we will determine whether the induction of HO-1 and CO synthesis in hyperhomocysteinemia functions in an adaptive manner to preserve endothelial function and blood pressure. In aim 3, we will investigate whether the dysregulation of CO synthesis in diabetes contributes to the development of endothelial dysfunction. In addition, we will examine whether restoration of endogenous CO synthesis or exogenous delivery of CO corrects endothelial function and regrowth following arterial injury. It is anticipated that these studies will establish the HO-1/CO system as a critical regulator of EC function, and will identify CO as a novel therapeutic modality in preventing endothelial dysfunction and vascular disease.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.freeradbiomed.2016.03.003
发表时间:
2016-05
期刊:
Free radical biology & medicine
影响因子:
7.4
作者:
[Liu XM, Durante ZE, Peyton KJ, Durante W]
通讯作者:
Durante W
DOI:
10.3389/fphar.2012.00048
发表时间:
2012
期刊:
Frontiers in pharmacology
影响因子:
5.6
作者:
[Peyton KJ, Shebib AR, Azam MA, Liu XM, Tulis DA, Durante W]
通讯作者:
Durante W
DOI:
10.1016/j.freeradbiomed.2016.11.029
发表时间:
2017-01
期刊:
FREE RADICAL BIOLOGY AND MEDICINE
影响因子:
7.4
作者:
[Liu, Xiao-Ming, Peyton, Kelly J., Durante, William]
通讯作者:
Durante, William
DOI:
10.2741/3860
发表时间:
2011-06-01
期刊:
Frontiers in bioscience (Landmark edition)
影响因子:
--
作者:
[Durante W]
通讯作者:
Durante W
DOI:
10.2741/e761
发表时间:
2016-01-01
期刊:
Frontiers in bioscience (Elite edition)
影响因子:
--
作者:
[Peyton KJ, Liu XM, Durante W]
通讯作者:
Durante W
共 23 条
Glutaminase in Arterial Injury and Disease
-
批准号:10630196
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2021
-
负责人:WILLIAM DURANTE
-
依托单位:
Glutaminase in Arterial Injury and Disease
-
批准号:10473678
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2021
-
负责人:WILLIAM DURANTE
-
依托单位:
Glutaminase in Arterial Injury and Disease
-
批准号:10209076
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2021
-
负责人:WILLIAM DURANTE
-
依托单位:
ARGINASE AND ARTERIAL INJURY
-
批准号:6926566
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2005
-
负责人:WILLIAM DURANTE
-
依托单位:
ARGINASE AND ARTERIAL INJURY
-
批准号:7188644
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2005
-
负责人:WILLIAM DURANTE
-
依托单位:
ARGINASE AND ARTERIAL INJURY
-
批准号:7576180
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2005
-
负责人:WILLIAM DURANTE
-
依托单位:
ARGINASE AND ARTERIAL INJURY
-
批准号:7385019
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2005
-
负责人:WILLIAM DURANTE
-
依托单位:
ARGINASE AND ARTERIAL INJURY
-
批准号:7039211
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2005
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:7025793
-
项目类别:
-
资助金额:$25.12万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:2759125
-
项目类别:
-
资助金额:$19.01万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:6476830
-
项目类别:
-
资助金额:$20.98万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:6861701
-
项目类别:
-
资助金额:$26.34万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:6719586
-
项目类别:
-
资助金额:$26.34万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
Carbon monoxide and vascular cell function
-
批准号:7996600
-
项目类别:
-
资助金额:$33.44万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:6125867
-
项目类别:
-
资助金额:$19.66万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:6330154
-
项目类别:
-
资助金额:$20.37万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
Carbon monoxide and vascular cell function
-
批准号:8212005
-
项目类别:
-
资助金额:$33.1万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
CARBON MONOXIDE AND VASCULAR SMOOTH MUSCLE CELL FUNCTION
-
批准号:6616653
-
项目类别:
-
资助金额:$26.34万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
Carbon monoxide and vascular cell function
-
批准号:7743398
-
项目类别:
-
资助金额:$33.45万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
Carbon monoxide and vascular cell function
-
批准号:7578761
-
项目类别:
-
资助金额:$33.46万
-
财政年份:1998
-
负责人:WILLIAM DURANTE
-
依托单位:
海外基金